Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas.

cardiomyopathy myocardial stunning myocarditis paraganglioma pheochromocytoma takotsubo syndrome

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Jul 2020
Historique:
received: 20 06 2020
revised: 14 07 2020
accepted: 28 07 2020
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

Pheochromocytomas and paragangliomas (PPGLs) are rare neuro-endocrine tumors. The catecholamine surge causes paroxysmal or chronic secondary hypertension. PPGLs may present as hypertensive- or PPGL-crisis with severe life-threatening cardiac and cerebrovascular complications. PPGLs-induced cardiac manifestations have been reported with diagnoses as PPGLs-induced electrocardiogram (ECG) changes "mimicking acute myocardial infarction", arrhythmias, myocarditis, acute coronary syndrome, dilated cardiomyopathy, and lately as takotsubo syndrome. Critical analysis of these reports reveals that most of these cardiac manifestations have certain features in common. They have a dramatic clinical presentation and are reversible if the disease is treated with appropriate medical therapy and surgical resection of the PPGL tumor. They may have the same repolarization ECG changes irrespective of the clinical cardiac diagnosis, usually associated with mild to moderate elevations of myocardial biomarkers as troponins and normal coronary arteries. The histopathological findings are usually focal or multifocal in the form hypercontracted sarcomeres and contraction band necrosis (myofibrillar degeneration) with subsequent secondary mononuclear cell infiltration. Evidences argue the PPGL caused surge of catecholamines triggers hyperactivation of the sympathetic nervous system with cardiac sympathetic nerve terminal disruption with norepinephrine spillover causing the cardiac complications. A comprehensive review of various reported cardiovascular manifestations and complications of PPGLs are presented.

Identifiants

pubmed: 32751501
pii: jcm9082435
doi: 10.3390/jcm9082435
pmc: PMC7465968
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Magnus Bergvalls Stiftelse
ID : 2017-02138, 2018-02566 and 2019-03149
Organisme : Magnus Bergvalls Stiftelse
ID : 2017-02138, 2018-02566 and 2019-03149

Références

Pediatr Emerg Care. 2002 Feb;18(1):33-5
pubmed: 11862137
Am Heart J. 1988 Nov;116(5 Pt 1):1363-5
pubmed: 3189154
Endocr Pract. 2015 Aug;21(8):870-7
pubmed: 26121453
Am Heart J. 1954 Jul;48(1):42-53
pubmed: 13171324
Am J Med. 1986 Nov;81(5):921-2
pubmed: 3776997
Am Heart J. 1972 May;83(5):688-93
pubmed: 5025594
Front Endocrinol (Lausanne). 2020 Mar 18;11:140
pubmed: 32256452
Tex Heart Inst J. 1993;20(2):120-2
pubmed: 8334363
Br Heart J. 1990 Apr;63(4):234-7
pubmed: 2337495
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
Am J Cardiol. 1972 Apr;29(4):568-71
pubmed: 5016838
CMAJ. 1990 Jan 15;142(2):99-100
pubmed: 2295041
Proc (Bayl Univ Med Cent). 2019 Mar 15;32(1):119-120
pubmed: 30956604
Endocrinol Diabetes Metab Case Rep. 2019 Oct 19;2019:
pubmed: 31634865
Horm Metab Res. 2012 May;44(5):379-84
pubmed: 22517556
Cardiology. 1993;83(1-2):118-20
pubmed: 8261476
J Hypertens. 2020 Aug;38(8):1443-1456
pubmed: 32412940
Int J Clin Pract. 2003 Nov;57(9):842-3
pubmed: 14686578
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1477-8
pubmed: 6405848
Cardiovasc Revasc Med. 2018 Dec;19(8S):2-4
pubmed: 29804797
Eur Heart J. 2018 Jun 7;39(22):2047-2062
pubmed: 29850820
Neurol Clin. 1993 May;11(2):273-92
pubmed: 8316186
A A Case Rep. 2017 Feb 1;8(3):58-60
pubmed: 27828782
Curr Hypertens Rep. 2018 Jan 22;20(1):3
pubmed: 29356966
Am Heart J. 1951 Sep;42(3):460-6
pubmed: 14877741
Cardiovasc Revasc Med. 2014 Jul-Aug;15(5):311-2
pubmed: 24560300
Int J Cardiol. 2015;187:304-6
pubmed: 25839628
Int J Cardiol. 1998 Aug;65(3):305-10
pubmed: 9740490
Int J Cardiol. 2015 Jul 15;191:237-43
pubmed: 25981361
J Clin Endocrinol Metab. 2019 May 1;104(5):1386-1393
pubmed: 30462226
J Med Case Rep. 2017 Jun 23;11(1):173
pubmed: 28641581
N Engl J Med. 1966 May 19;274(20):1102-8
pubmed: 5932021
Horm Metab Res. 2019 Jul;51(7):458-469
pubmed: 30227459
Medicine (Baltimore). 2015 Dec;94(50):e2198
pubmed: 26683930
Angiology. 1994 Nov;45(11):985-9
pubmed: 7978515
J Endocr Soc. 2019 Jun 11;3(8):1518-1530
pubmed: 31384714
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 31714582
Int J Legal Med. 2001 Dec;115(3):142-51
pubmed: 11775016
Int J Cardiol. 2015;187:369-71
pubmed: 25841128
Ann Intern Med. 2001 Feb 20;134(4):315-29
pubmed: 11182843
Clin Auton Res. 2018 Feb;28(1):53-65
pubmed: 28917022
Br Heart J. 1987 Feb;57(2):194-8
pubmed: 3814455
J Clin Endocrinol Metab. 2010 May;95(5):2023-37
pubmed: 20215394
Eur Heart J. 2017 May 14;38(19):1522-1523
pubmed: 28025185
J Nucl Med. 1983 Dec;24(12):1127-34
pubmed: 6644373
Endocrine. 2019 Sep;65(3):483-493
pubmed: 31399912
Eur J Endocrinol. 2015 Dec;173(6):757-64
pubmed: 26346138
Kaku Igaku. 1995 Sep;32(9):1023-8
pubmed: 8523838
BMC Endocr Disord. 2015 Feb 27;15:6
pubmed: 25887139
Heart. 2013 Oct;99(19):1438-44
pubmed: 23837998
Int J Cardiol. 2017 Feb 1;228:528-536
pubmed: 27875730
Am J Cardiol. 1987 Dec 28;60(18):15J-19J
pubmed: 3321964
Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):22-9
pubmed: 18094670
ISRN Cardiol. 2012;2012:593735
pubmed: 23119184
Scott Med J. 1991 Dec;36(6):184
pubmed: 1805381
J Am Coll Cardiol. 2016 May 24;67(20):2364-2374
pubmed: 27199060
Am Heart J. 1987 Aug;114(2):423-7
pubmed: 3496776
Cardiovasc Revasc Med. 2019 Oct;20(10):907-914
pubmed: 30446399
Chest. 1996 May;109(5):1394-7
pubmed: 8625697
Am Heart J. 1981 Aug;102(2):286-90
pubmed: 7196146
Jpn Circ J. 1994 Sep;58(9):737-42
pubmed: 7967019
J Cardiol. 1991;21(2):203-14
pubmed: 1841907
Jpn Heart J. 1999 Nov;40(6):683-701
pubmed: 10737553
Ann Intern Med. 1957 Jun;46(6):1165-77
pubmed: 13435665
J Electrocardiol. 1991 Jul;24(3):267-75
pubmed: 1919387
Am J Cardiol. 2016 Jun 1;117(11):1836-44
pubmed: 27103159
J Clin Endocrinol Metab. 2000 Feb;85(2):637-44
pubmed: 10690869
Prog Cardiovasc Dis. 1974 Jul-Aug;17(1):73-86
pubmed: 4599470
Arch Pathol. 1967 Nov;84(5):517-21
pubmed: 6054616
Br Med J. 1976 Oct 2;2(6039):793-4
pubmed: 974613
Am J Emerg Med. 2018 Feb;36(2):344.e1-344.e4
pubmed: 29146416
Intern Med. 2017;56(6):665-671
pubmed: 28321067
Endocr Connect. 2018 Jan;7(1):186-192
pubmed: 29217652
Clin Nucl Med. 1999 Jul;24(7):514-8
pubmed: 10402006
N Engl J Med. 1987 Mar 26;316(13):793-7
pubmed: 2881206
Int J Cardiol. 2013 Jul 1;166(3):736-7
pubmed: 23073280
Chest. 1991 Feb;99(2):382-5
pubmed: 1671211
Horm Metab Res. 2019 Jul;51(7):401-402
pubmed: 31307107
Endocrine. 2018 Dec;62(3):566-575
pubmed: 30220006
Eur Heart J. 2009 Jul;30(13):1635-42
pubmed: 19389788
Br Med J (Clin Res Ed). 1985 Dec 14;291(6510):1724-5
pubmed: 3935263
J Clin Endocrinol Metab. 2003 Aug;88(8):3632-6
pubmed: 12915647
Cent European J Urol. 2014;67(2):153-5
pubmed: 25140229
Acta Cardiol. 1998;53(4):227-9
pubmed: 9842409
Endocr Pract. 2017 Oct;23(10):1178-1192
pubmed: 28704094
Eur Heart J. 2007 Oct;28(20):2456-64
pubmed: 17395683
Cardiovasc Revasc Med. 2014 Jan;15(1):35-42
pubmed: 24140050
Endocrine. 2020 Mar;67(3):727-728
pubmed: 31883060
Ann Cardiol Angeiol (Paris). 2010 Feb;59(1):52-3
pubmed: 19963206
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
Arch Mal Coeur Vaiss. 1976 Jan;69(1):49-58
pubmed: 823887
Chest. 1976 Sep;70(03):397-9
pubmed: 954472
Aust N Z J Surg. 1969 May;38(4):324-8
pubmed: 4892232
Jpn Circ J. 1989 Jul;53(7):813-8
pubmed: 2810691
Nihon Naibunpi Gakkai Zasshi. 1990 Jan 20;66(1):1-8
pubmed: 1968401
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Clin Cardiol. 2020 May;43(5):459-467
pubmed: 32125009
Ann Cardiol Angeiol (Paris). 2000 Dec;49(8):449-54
pubmed: 12555432
Pediatr Blood Cancer. 2020 Aug;67(8):e28332
pubmed: 32491270
BMJ Case Rep. 2018 Jun 8;2018:
pubmed: 29884661
J Am Osteopath Assoc. 2017 Aug 1;117(8):537-540
pubmed: 28759096
Am Heart J. 1991 Feb;121(2 Pt 1):610-3
pubmed: 1990775
J Clin Endocrinol Metab. 2005 Apr;90(4):2110-6
pubmed: 15644401
Hum Pathol. 1986 Jan;17(1):9-13
pubmed: 2417934
J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 1):363-6
pubmed: 1576142
Int J Cardiol. 2017 Dec 15;249:319-323
pubmed: 29121733
South Med J. 1990 Dec;83(12):1478-80
pubmed: 2251539
Br Med J. 1952 Oct 18;2(4789):860-2
pubmed: 12978359
N Engl J Med. 1988 Apr 14;318(15):970-81
pubmed: 3352687
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3296-3305
pubmed: 28605453
Endokrynol Pol. 2019;70(3):298-303
pubmed: 30351443
Proc (Bayl Univ Med Cent). 2017 Jul;30(3):314-315
pubmed: 28670069
Am J Cardiol. 1961 Sep;8:426-30
pubmed: 13768321
G Ital Cardiol. 1975;5(5):779-83
pubmed: 1205050
J Am Soc Echocardiogr. 1993 May-Jun;6(3 Pt 1):327-31
pubmed: 8333984
Calif Med. 1972 Oct;117(4):58-60
pubmed: 5075723
Z Kardiol. 2001 Apr;90(4):297-303
pubmed: 11381579
Circulation. 2007 Jul 3;116(1):77-84
pubmed: 17606855
J Nucl Med. 1985 Apr;26(4):357-65
pubmed: 3981255
Int J Cardiol. 2015 Jul 15;191:267-9
pubmed: 25978612

Auteurs

Shams Y-Hassan (S)

Coronary Artery Disease Area, Heart and Vascular Theme, Karolinska Institutet and Karolinska University Hospital, 141 86 Stockholm, Sweden.

Henrik Falhammar (H)

Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.

Classifications MeSH